ライフサイエンスコーパス: immunosorbent

1 Our biolayer interferometry immunosorbent assay (BLI-ISA) utilizes single-use biosen

2 describe an electronics-based Enzyme-Linked ImmunoSorbent Assay (eELISA), using a Lab-on-a-Printed C

3 iagnostic performance of a CRP enzyme-linked immunosorbent assay (ELISA) (Eurolyser) in comparison to

4 levels of tropomyosin by using enzyme-linked immunosorbent assay (ELISA) among raw and cooked crab sp

5 In immunohistochemical and enzyme-linked immunosorbent assay (ELISA) analyses of tissue and cyst

6 Through an enzyme-linked immunosorbent assay (ELISA) and a histo-blood group anti

7 9 antibody tests, including an enzyme linked immunosorbent assay (ELISA) and a Luminex-based microsph

8 igh complexity methods such as Enzyme-Linked Immunosorbent Assay (ELISA) and Chemiluminescent Immunoa

9 esults of whole-bacterial-cell enzyme-linked immunosorbent assay (ELISA) and flow cytometry experimen

10 patica-specific serum antibody enzyme-linked immunosorbent assay (ELISA) and fluke egg counts.

11 F and serum were quantified by enzyme-linked immunosorbent assay (ELISA) and reported as total amount

12 The second assay is enzyme-linked immunosorbent assay (ELISA) based and can measure compet

13 arable or better than standard enzyme-linked immunosorbent assay (ELISA) directly from unprocessed sa

14 ific IgM and IgG antibodies by enzyme-linked immunosorbent assay (ELISA) for 126 study participants.

15 Fab/scFv in the context of an enzyme-linked immunosorbent assay (ELISA) for HBeAg quantification, wh

16 developed a sensitive sandwich enzyme-linked immunosorbent assay (ELISA) for PEG by tethering an anti

17 fold improvement over standard enzyme-linked immunosorbent assay (ELISA) for protein detection, being

18 , we report a new quantitative enzyme-linked immunosorbent assay (ELISA) for seasonal trivalent influ

19 pplied it in an ultrasensitive enzyme-linked immunosorbent assay (ELISA) for the detection of benzo[a

20 rcially available, serum-based enzyme-linked immunosorbent assay (ELISA) for use with saliva samples,

21 ZEBOV-GP enzyme-linked immunosorbent assay (ELISA) geometric mean titers (GMTs)

22 Enzyme-linked immunosorbent assay (ELISA) is a widely used standard me

23 Enzyme-linked immunosorbent assay (ELISA) is a widely used technique f

24 The enzyme-linked immunosorbent assay (ELISA) is commonly used throughout

25 Enzyme-linked immunosorbent assay (ELISA) is the gold standard method

26 tify using currently available enzyme-linked immunosorbent assay (ELISA) kits and, therefore, this hi

27 ose obtained with conventional enzyme-linked immunosorbent assay (ELISA) methodologies and in 2-5 tim

28 ation through a CXCL12 protein enzyme-linked immunosorbent assay (ELISA) on patient serum at baseline

29 sessed cytokine production via enzyme-linked immunosorbent assay (ELISA) or V-Plex, and mRNA levels w

30 Enzyme-linked immunosorbent assay (ELISA) performed on supernatant flu

31 Competitive enzyme-linked immunosorbent assay (ELISA) studies showed that the DARP

32 Moreover, enzyme-linked immunosorbent assay (ELISA) tests were negative for mack

33 erological techniques like the enzyme-linked immunosorbent assay (ELISA) to detect antibody responses

34 he pathway toward a recognized enzyme-linked immunosorbent assay (ELISA) to determine serum immunoglo

35 atural enzyme in a traditional enzyme-linked immunosorbent assay (ELISA) to establish a nanozyme-base

36 Toxoplasma gondii IgA antibody enzyme-linked immunosorbent assay (ELISA) to the serologic panel of te

37 iters reaching several million enzyme-linked immunosorbent assay (ELISA) units.

38 e state of the art method, the enzyme linked immunosorbent assay (ELISA) used in clinics, because it

39 odium antigen in a fluorescent enzyme-linked immunosorbent assay (ELISA) using a fluorescence substra

40 We evaluated these antigens by enzyme-linked immunosorbent assay (ELISA) using sera from naive rabbit

41 ensor was compared to standard enzyme-linked immunosorbent assay (ELISA) using unstimulated saliva sa

42 y superior to that of the Zeus enzyme-linked immunosorbent assay (ELISA) VZV IgG assay (Zeus Diagnost

43 This enzyme-linked immunosorbent assay (ELISA) was based on spotting differ

44 A novel enzyme-linked immunosorbent assay (ELISA) was developed for the detect

45 ia trachomatis elementary body enzyme-linked immunosorbent assay (ELISA) was used to investigate seru

46 and rubella determined by IgG enzyme-linked immunosorbent assay (ELISA) were 93, 93, and 100%, respe

47 well as 44 serum samples from enzyme-linked immunosorbent assay (ELISA) West Nile- and dengue-positi

48 ients from healthy subjects by enzyme-linked immunosorbent assay (ELISA) with sensitivity and specifi

49 he following 4 patient groups: enzyme-linked immunosorbent assay (ELISA)+/serotonin-release assay (SR

50 k increased cBIN1 detection by enzyme-linked immunosorbent assay (ELISA), and cBIN1 level decreased i

51 -M41 receptor was confirmed by enzyme-linked immunosorbent assay (ELISA), demonstrating that tissue b

52 lite levels were determined by enzyme-linked immunosorbent assay (ELISA), for Human Abeta and soluble

53 ated proteins were assessed by enzyme-linked immunosorbent assay (ELISA), histology, and immunohistoc

54 ass Spectrometry (UPLC-MS) and Enzyme-Linked Immunosorbent Assay (ELISA), including higher sensitivit

55 evels are usually monitored by enzyme-linked immunosorbent assay (ELISA), liquid chromatography coupl

56 rely on Gram stains, cultures, Enzyme linked immunosorbent assay (ELISA), polymerase chain reaction (

57 diagnostics utilized included enzyme-linked immunosorbent assay (ELISA), rk39 test strips, quantitat

58 Using enzyme-linked immunosorbent assay (ELISA), we obtain seropositivity of

59 tralizing antibodies), and the enzyme-linked immunosorbent assay (ELISA), which measures total immuno

60 Here, we developed a simple enzyme-linked immunosorbent assay (ELISA)-based assay that uses the te

61 hed and used multiple indirect Enzyme Linked Immunosorbent Assay (ELISA)-based serological assays to

62 ples, compared to conventional enzyme-linked immunosorbent assay (ELISA).

63 RS-CoV-2 antibodies testing by enzyme-linked immunosorbent assay (ELISA).

64 ype was determined by salivary enzyme-linked immunosorbent assay (ELISA).

65 orozoite protein (PfCSP) using enzyme-linked immunosorbent assay (ELISA).

66 J using metabololipidomics and enzyme-linked immunosorbent assay (ELISA).

67 tion was quantified by albumin enzyme-linked immunosorbent assay (ELISA).

68 gnostic antigen in an indirect enzyme-linked immunosorbent assay (ELISA).

69 vax and P. falciparum using an enzyme-linked immunosorbent assay (ELISA).

70 els were assayed via multiplex enzyme-linked immunosorbent assay (ELISA).

71 exes and ADAs were measured by enzyme-linked immunosorbent assay (ELISA).

72 trations were determined by an enzyme-linked immunosorbent assay (ELISA).

73 y is as good as or better than enzyme-linked immunosorbent assay (ELISA).

74 for NE using a single-analyte enzyme-linked immunosorbent assay (ELISA).

75 that can be used to conduct an enzyme-linked immunosorbent assay (ELISA).

76 nd validated it by competitive enzyme-linked immunosorbent assay (ELISA).

77 ow cytometry, and cytokines by enzyme-linked immunosorbent assay (ELISA).

78 (n=297), we measured apo M by Enzyme-Linked ImmunoSorbent Assay (ELISA).

79 the plasma were measured by an enzyme-linked immunosorbent assay (ELISA).

80 dies were measured by means of enzyme-linked immunosorbent assay (ELISA).

81 which was further compared to enzyme-linked immunosorbent assay (ELISA).

82 l detection method, such as an enzyme-linked immunosorbent assay (ELISA).

83 and employed in a competitive enzyme-linked immunosorbent assay (ELISA).

84 cial SARS-CoV-2 total antibody enzyme-linked immunosorbent assay (ELISA, Wantai Biological Pharmacy E

85 g these antibodies, a sandwich enzyme-linked immunosorbent assay (LAM-ELISA) was developed to quantit

86 using an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) for screening, followed

87 bulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA).

88 ndicator molecules for allochroic NPs-linked immunosorbent assay (named ALISA) of ER, PR, and HER2, r

89 n reaction (messenger RNA) and enzyme-linked immunosorbent assay (protein).

90 ollected in 211 patients using enzyme-linked immunosorbent assay (Tac/Sir = 104, Tac/Mtx = 107).

91 ) and tumor necrosis factor by enzyme-linked immunosorbent assay (test cohort).

92 developed a competitive upconversion-linked immunosorbent assay (ULISA) for the analysis of zearalen

93 A VP2-peptide enzyme-linked immunosorbent assay (VP2-ELISA) was optimized using expe

94 etect 2.0 IgM antibody capture enzyme-linked immunosorbent assay (ZIKV 2.0 MAC-ELISA; InBios internat

95 nti-spike protein response (in enzyme-linked immunosorbent assay [ELISA] units).

96 iple tissues were estimated by enzyme-linked immunosorbent assay analysis.

97 using a ZIKV immunoglobulin G enzyme-linked immunosorbent assay and a virus neutralization assay.

98 Several methods like enzyme-linked immunosorbent assay and affinity chromatography are comm

99 s measured by the standard p24 enzyme-linked immunosorbent assay and an ultrasensitive p24 assay (Sim

100 easured levels of S100A8-A9 by enzyme-linked immunosorbent assay and analyzed fecal microbiomes by 16

101 ayed for IL-1beta and IL-10 by enzyme-linked immunosorbent assay and compared using the Mann-Whitney

102 reactive proteins validated by enzyme-linked immunosorbent assay and demonstrate the effect of novel

103 ament light chain (NfL), using enzyme-linked immunosorbent assay and electrochemiluminescence.

104 ogeneous bead-based electronic enzyme-linked immunosorbent assay and find that experimental results a

105 e developed a highly sensitive enzyme-linked immunosorbent assay and found that HN3-ABD-T20 had a 45-

106 We measured levels of IFNL by enzyme-linked immunosorbent assay and immunohistochemistry and locatio

107 her confirmed by Western blot, enzyme-linked immunosorbent assay and immunohistochemistry, and associ

108 MERS-CoV nucleocapsid protein enzyme-linked immunosorbent assay and indirect immunofluorescence, wit

109 owth factors with immunoassay (enzyme-linked immunosorbent assay and Luminex).

110 dings of 2 orthogonal methods, enzyme-linked immunosorbent assay and mass spectrometry, to validate t

111 Enzyme-linked immunosorbent assay and microsphere-based flow cytometri

112 d fecal pancreatic elastase by enzyme-linked immunosorbent assay and performed quantitative imaging o

113 Prospective determination of enzyme-linked immunosorbent assay anti-RBD IgG titer facilitated selec

114 igher with higher dose (day 29 enzyme-linked immunosorbent assay anti-S-2P antibody geometric mean ti

115 G titers were quantified using enzyme-linked immunosorbent assay at 4.5 years.

116 itive double antibody sandwich enzyme-linked immunosorbent assay at baseline and 2 weeks.

117 s using a comparative indirect enzyme-linked immunosorbent assay based on the recombinant NiV nucleoc

118 ters were measured by means of enzyme-linked immunosorbent assay before and 1 month after each vaccin

119 tibody titers were measured by enzyme-linked immunosorbent assay before and after each dose; geometri

120 ergent extracts tested by 82E1 enzyme-linked immunosorbent assay confirmed the presence of bona fide

121 Using an indirect enzyme-linked immunosorbent assay for all 5 muscarinic receptors (M(1)

122 were also screened by means of enzyme-linked immunosorbent assay for antibodies reactive with Nipah G

123 formed for cell damage, and an enzyme-linked immunosorbent assay for cytokine expression.

124 patients with BP underwent an enzyme-linked immunosorbent assay for IgE antibodies against the 16th

125 tal of 197 specimens tested by enzyme-linked immunosorbent assay for IgM, IgG, and IgA anti-SARS-CoV-

126 ted a high correlation with an enzyme-linked immunosorbent assay for sample detection in patients.

127 ere, we describe a serological enzyme-linked immunosorbent assay for the screening and identification

128 e developed in two alternative enzyme-linked immunosorbent assay formats, using homologous and hetero

129 phase were processed using an enzyme-linked immunosorbent assay from a single batch.

130 s performance is comparable to enzyme-linked immunosorbent assay from the studies on clinical samples

131 GAP-43 was measured using an enzyme-linked immunosorbent assay in 105 MS patients (73 RRMS, 12 prim

132 s were investigated by PCR and enzyme-linked immunosorbent assay in an in vitro diabetes model.

133 to these antigens by means of enzyme-linked immunosorbent assay in patients with suspected enteric f

134 tein levels were analyzed with enzyme-linked immunosorbent assay in repeated samples.

135 method based on fiber optic nanogold-linked immunosorbent assay is reported.

136 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay is used to consider immediate treatm

137 pared to a commercial sandwich enzyme-linked immunosorbent assay kit.

138 als was highly correlated with enzyme-linked immunosorbent assay measurements; moreover, the ApoA1 co

139 implant crevicular fluid using enzyme-linked immunosorbent assay method and assessed with clinical pa

140 levels were analyzed using an enzyme-linked immunosorbent assay method.

141 tly validated using Luminex or enzyme-linked immunosorbent assay methods.

142 rst detected by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their assoc

143 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density greater than or equa

144 aluate the applicability of an enzyme-linked immunosorbent assay optical density threshold less than

145 to evaluate the application of enzyme-linked immunosorbent assay optical density thresholds and the s

146 ty and specificity analysis of enzyme-linked immunosorbent assay optical density thresholds, heparin-

147 e proteins were immobilized on enzyme-linked immunosorbent assay plates in their native form and assa

148 se assay, and immunoglobulin G enzyme-linked immunosorbent assay positive) and serotonin release assa

149 Enzyme-linked immunosorbent assay revealed that the former secretes la

150 (RT-PCR) and immunoglobulin M enzyme-linked immunosorbent assay testing to detect ZIKV infection.

151 dy [PRNT80 titers, 40-640] and enzyme-linked immunosorbent assay titers) after the boost.

152 We developed an enzyme-linked immunosorbent assay to measure anti-DENV NS1 IgG in sera

153 We used an enzyme-linked immunosorbent assay to measure levels of spontaneous rel

154 ols (CON, n = 14), we utilized enzyme-linked immunosorbent assay to measure NFL and protein misfoldin

155 By co-immunoprecipitation and enzyme-linked immunosorbent assay using recombinant proteins, we verif

156 zed galectin-9 serum levels by enzyme-linked immunosorbent assay using serum samples from 70 patients

157 An in-house enzyme-linked immunosorbent assay utilizing recombinant receptor-bindi

158 Enzyme-linked immunosorbent assay was used to assess levels of MMP-9 a

159 Enzyme-linked immunosorbent assay was used to determine levels of thes

160 Enzyme-linked immunosorbent assay was used to determine the amount of

161 Enzyme-linked immunosorbent assay was used to determine the levels of

162 titer (measured by inhibition enzyme-linked immunosorbent assay) and dengue severity, categorized us

163 d in serum samples by means of enzyme-linked immunosorbent assay, and coronary atherosclerosis was as

164 eased levels of PGE2, based on enzyme-linked immunosorbent assay, and COX2 messenger RNA and protein,

165 via surface plasmon resonance, enzyme-linked immunosorbent assay, and flow cytometry.

166 analyzed using immunostaining, enzyme-linked immunosorbent assay, and heparanase procoagulant activit

167 e analyzed via immunostaining, enzyme-linked immunosorbent assay, and heparanase procoagulant activit

168 n, real-time quantitative PCR, enzyme-linked immunosorbent assay, and immunohistochemical analyses.

169 e analyzed by gliadin antibody enzyme-linked immunosorbent assay, and intestinal tissues were analyze

170 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, and serotonin release assay scores.

171 CRP measurements were made by enzyme-linked immunosorbent assay, and venepuncture samples by a refer

172 s found to bind vitronectin by enzyme-linked immunosorbent assay, as isolated PE does.

173 omatography-mass spectrometry, enzyme-linked immunosorbent assay, capillary electrophoresis, electroc

174 r functions were determined by enzyme-linked immunosorbent assay, carboxyfluorescein succinimidyl est

175 activated cell sorting (FACS), enzyme-linked immunosorbent assay, immunofluorescence (IF), and immuno

176 o VAR2CSA was characterized by enzyme-linked immunosorbent assay, immunofluorescence assay, and flow

177 ion polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytome

178 Using enzyme-linked immunosorbent assay, immunohistochemistry, and ex vivo s

179 tion of monoclonal antibodies (enzyme-linked immunosorbent assay, or "ELISA"), to small molecule liga

180 zed using HEV antigen-specific enzyme-linked immunosorbent assay, reverse transcription-quantitative

181 measured using flow cytometry, enzyme-linked immunosorbent assay, RNA in situ hybridization, and quan

182 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, serotonin release assay, and Warken

183 lonal antibodies by inhibition enzyme-linked immunosorbent assay, surface plasmon resonance, and comp

184 sted with the immunoglobulin G enzyme-linked immunosorbent assay, the serotonin release assay and hep

185 anti-Cas9 antibodies using an enzyme-linked immunosorbent assay, we detected antibodies against both

186 total antibodies, detected by enzyme-linked immunosorbent assay, were the best predictor of function

187 s immunoassay formats, such as enzyme-linked immunosorbent assay, Western blot, and lateral flow assa

188 ntional techniques such as the enzyme-linked immunosorbent assay, Western Blot, and mass spectrometry

189 MP1 protein and mRNA levels were analyzed by immunosorbent assay, Western blotting and quantitative P

190 based HIV-1 p24 capsid protein enzyme-linked immunosorbent assay, which achieved a recovery rate of u

191 were also explored through an enzyme-linked immunosorbent assay-based measurement of nuclear NF-kapp

192 system to a sensitive sandwich enzyme-linked immunosorbent assay-like assay of cannabidiol in body fl

193 polymerase chain reaction, and enzyme-linked immunosorbent assay.

194 ssessed via flow cytometry and enzyme-linked immunosorbent assay.

195 utination inhibition assay and enzyme-linked immunosorbent assay.

196 ured using the fluorescence-based micro-bead immunosorbent assay.

197 body titers were quantified by enzyme-linked immunosorbent assay.

198 say and a Competitive Indirect Enzyme-linked immunosorbent assay.

199 reement with those realized from enzyme-link immunosorbent assay.

200 orozoite protein (PfCSP) using enzyme-linked immunosorbent assay.

201 pha, were measured by means of enzyme-linked immunosorbent assay.

202 d with CAP were measured using enzyme-linked immunosorbent assay.

203 aluate cytokine profiles using Enzyme-Linked Immunosorbent Assay.

204 gM) and immunoglobulin G (IgG) enzyme-linked immunosorbent assay.

205 ng a virus-like particle-based enzyme-linked immunosorbent assay.

206 rmined in an in vitro model by enzyme-linked immunosorbent assay.

207 -end labeling and DNA fragment enzyme-linked immunosorbent assay.

208 tibodies were determined using enzyme-linked immunosorbent assay.

209 MP-8 levels were determined by enzyme-linked immunosorbent assay.

210 ncentration was measured by an enzyme-linked immunosorbent assay.

211 ti-PEG-ASP immunoglobulin G by enzyme-linked immunosorbent assay.

212 sing multiplex immunoassay and enzyme-linked immunosorbent assay.

213 (MMP-2) were measured using an enzyme-linked immunosorbent assay.

214 onin levels were determined by enzyme-linked immunosorbent assay.

215 -alpha levels were measured by enzyme-linked immunosorbent assay.

216 rithidia luciliae staining and enzyme-linked immunosorbent assay.

217 3 was assessed by competitive, enzyme-linked immunosorbent assay.

218 mbined with the IgG anti-BP180 enzyme-linked immunosorbent assay.

219 using a 17-plex Luminex kit or enzyme-linked immunosorbent assay.

220 2 in serum from 28 patients by enzyme-linked immunosorbent assay.

221 of biomarkers were measured by enzyme-linked immunosorbent assay.

222 to 18 months, for analysis by enzyme-linked immunosorbent assay.

223 TNF protein levels measured by enzyme-linked immunosorbent assay.

224 -2 complex were assessed using enzyme-linked immunosorbent assay.

225 m Klotho level was measured by enzyme-linked immunosorbent assay.

226 erum levels were determined by enzyme-linked immunosorbent assay.

227 ibody status was determined by enzyme-linked immunosorbent assay.

228 h fluid were measured using an enzyme-linked immunosorbent assay.

229 t reactions were conducted via enzyme-linked immunosorbent assay.

230 n expression was determined by enzyme-linked immunosorbent assay.

231 calprotectin were analyzed by enzyme-linked immunosorbent assay.

232 -cytokine multiplex bead-based enzyme-linked immunosorbent assay.

233 oadly reactive, genus-specific enzyme-linked immunosorbent assay.

234 10 AU/mL using a drug-tolerant enzyme-linked immunosorbent assay.

235 -specific ABs were assessed by enzyme-linked immunosorbent assay.

236 western-blotting, and also by enzyme-linked immunosorbent assay.

237 protein were detected by using enzyme-linked immunosorbent assay.

238 igand (sFASL) were measured by enzyme-linked immunosorbent assay.

239 culture supernatants using an enzyme-linked immunosorbent assay.

240 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay; 10 patients were identified as hepa

241 ral-flow rapid test as well as enzyme-linked-immunosorbent-assay (ELISA).

242 ateral flow devices (LFID) and enzyme linked immunosorbent assays (ELISA) are being adapted for the d

243 r's disease were quantified by enzyme-linked immunosorbent assays (ELISA) or theoretically calculated

244 Plasmonic enzyme-linked immunosorbent assays (ELISA) using the localized surface

245 mpdh2, which were validated by enzyme-linked immunosorbent assays (ELISA).

246 ere evaluated using commercial enzyme-linked immunosorbent assays (ELISA).

247 nd Lb6H, and evaluated both in enzyme-linked immunosorbent assays (ELISA).

248 Three enzyme-linked immunosorbent assays (ELISAs) (Hemagen, Ortho, and Wiene

249 specificities of 4 commercial enzyme-linked immunosorbent assays (ELISAs) and 2 rapid tests in 77 pa

250 2 detection tests and in-house enzyme-linked immunosorbent assays (ELISAs) and correlated serological

251 rin and chondroitin sulfate in enzyme-linked immunosorbent assays (ELISAs) and depended on heparan su

252 We reported previously that enzyme-linked immunosorbent assays (ELISAs) based on the nonstructural

253 Enzyme-linked immunosorbent assays (ELISAs) for BP180 and BP230 (MBL I

254 GST pulldown and indirect enzyme-linked immunosorbent assays (ELISAs) further confirmed that the

255 ibody detection via commercial enzyme-linked immunosorbent assays (ELISAs) is widely used for routine

256 a panel of class 5 adhesins in enzyme-linked immunosorbent assays (ELISAs) revealed several reactivit

257 o three commercially available enzyme-linked immunosorbent assays (ELISAs) targeting the nucleoprotei

258 IgG1 or IgG enzyme-linked immunosorbent assays (ELISAs) with rK39 or lysate antige

259 tead, using immunoblotting and enzyme-linked immunosorbent assays (ELISAs), we found that Msp activat

260 tigens ("crude antigen") using enzyme-linked immunosorbent assays (ELISAs).

261 oluble dimeric FcgammaRIIIa in enzyme-linked immunosorbent assays (ELISAs).

262 g quantitative, single-plexed, enzyme-linked immunosorbent assays (ELISAs).

263 diseases routinely detected by enzyme-linked immunosorbent assays (ELISAs).

264 DNF) were analysed by specific enzyme-linked immunosorbent assays (ELISAs).

265 double nanobodies in sandwich enzyme-linked immunosorbent assays (ELISAs).

266 d immunoglobulin A (IgA) and G enzyme-linked immunosorbent assays (ELISAs); NPW specimens were also c

267 (FAMA) assays and glycoprotein enzyme-linked immunosorbent assays (gpELISAs) were used to assess humo

268 ion-PCR (rRT-PCR), IgM capture enzyme-linked immunosorbent assays (IgM-ELISAs), and inhibition ELISAs

269 o-called single-molecule upconversion-linked immunosorbent assays (ULISAs).

270 Enzyme-linked immunosorbent assays against whole bacterial cells showe

271 at baseline using quantitative enzyme-linked immunosorbent assays and used to stratify patients into

272 Enzyme-linked immunosorbent assays are currently the most popular meth

273 CAM-1]) were measured by using enzyme-linked immunosorbent assays at 1 day, 2 weeks, and 5 weeks afte

274 he limit of detection in fluorescence-linked immunosorbent assays by up to 4,750-fold and is compatib

275 Enzyme-linked immunosorbent assays determined highly significant diffe

276 ure or positive results by two enzyme-linked immunosorbent assays for cases presenting with EM lesion

277 munoassay determined LTB4, and enzyme-linked immunosorbent assays quantified tumor necrosis factor (T

278 LFAs) and two laboratory-based enzyme-linked immunosorbent assays to detect anti-SARS-CoV-2 IgM and I

279 We also performed enzyme-linked immunosorbent assays using a recombinant wild-type 3c2.A

280 Capture enzyme-linked immunosorbent assays using specific rabbit IgG and chick

281 Bexsero, and Western blots and enzyme-linked immunosorbent assays were used to assess the generation

282 Comparative enzyme-linked immunosorbent assays with monoclonal antibodies against

283 unoblot, immunohistochemistry, enzyme-linked immunosorbent assays, and metabolite assays; cells and t

284 ith the use of protein arrays, enzyme-linked immunosorbent assays, and Western blot analyses.

285 Using enzyme-linked immunosorbent assays, levels of antibody response were m

286 polymerase chain reaction and enzyme-linked immunosorbent assays, respectively.

287 ATG was analyzed via multiplex enzyme-linked immunosorbent assays.

288 de (Pg-LPS) stimulation, using enzyme-linked immunosorbent assays.

289 ly measured using quantitative enzyme-linked immunosorbent assays.

290 (GCF) of all participants via enzyme-linked immunosorbent assays.

291 lot, and functional assays and enzyme-linked immunosorbent assays.

292 ere evaluated using commercial enzyme-linked immunosorbent assays.

293 and PGI and PGII levels using enzyme linked immunosorbent assays.

294 es based on flow cytometry and enzyme-linked immunosorbent assays.

295 immunoprecipitation (LIPS) and enzyme-linked immunosorbent (ELISA) immunoassays.

296 d a CMV-specific peptide-based enzyme-linked immunosorbent spot (ELISPOT) assay to determine whether

297 interleukin-4 (IL-4) T-helper enzyme-linked immunosorbent spot (ELISpot) assays of the CD4bs-occlude

298 In cultured enzyme-linked immunosorbent spot (ELISpot) assays, individuals with ch

299 sed them in a gamma interferon enzyme-linked immunosorbent spot assay to interrogate CD8(+) and CD4(+

300 ssed using an interferon gamma enzyme-linked immunosorbent spot assay.